Recent data shows patients with chronic conditions are largely driving health care spending, yet many plans are seeing suboptimal outcomes. So, what...

To kick off the new year, Navitus' CEO, David Fields, shares his industry insights on what plan sponsors should watch for in 2021.

Hear first-hand how Texas Association of Counties (TAC) fine-tuned its Rx benefit plan performance and experienced significant savings. Watch the...

What are the latest developments with the COVID-19 vaccines? In this blog, we’ll discuss the current state of the COVID-19 vaccinations and what plan...

Drug benefits comprise more than 20% of overall healthcare costs, which represents a large portion of a plan sponsor’s budget.¹ For many plan...

Reducing spend is important, but shouldn't be your only priority when selecting a PBM. Chief Growth Officer Byron Mickle explains why strong customer...

Nearly 150 million people in the U.S. have at least one chronic illness, and as many as half fail to take their prescriptions appropriately.^1,2

In the second part of this two-part blog series, we’ll discuss a few tools that plan sponsors can use to effectively combat opioid abuse and misuse...

During this two-part blog series, we'll discuss the opioid epidemic in its current state, the impact that coronavirus (COVID-19) is having on the...

More than 75% of pharmaceutical manufacturers are choosing to limit the number of pharmacies that can dispense certain specialty medications.¹ Find...

Is your PBM 100% transparent? If its not, it's time to take a closer look to see why.

How is the coronavirus (COVID-19) affecting prescription drug trends? Learn more.